Thermo Fisher Scientific (TMO) said Tuesday that it has agreed to acquire Solventum's (SOLV) Purification & Filtration business for $4.1 billion in cash.
Thermo said the deal, which is set to be completed by the end of the year, is expected to be dilutive to adjusted EPS by $0.06.
In a separate statement, Solventum said it expects the deal to be neutral to EPS this year.